Avastin
information and resources from the National Cancer Institute
Avastin
(Other name for: bevacizumab)Avelox
(Other name for: moxifloxacin hydrochloride)Avastin
(Other name for: bevacizumab)
|
|
|
|
news articles
Cancer: Two women tell their stories 01 Apr 2006
Independent, But there is one problem. Her health trust will provide funding only in exceptional cases for the drug, Avastin, that Ms Bailey desperately needs. ...
Sask. cancer patients increase pressure for Avastin funding Mar 27, 2006
StarPhoenix, ...cancer. The province has already said it will not pay for Avastin because it believes the hefty price tag outweighs its benefits. ...
Roche Avastin In Renal Cancer Next Big Driver Mar 27, 2006
newratings.com 1307 GMT [Dow Jones] Roche (RHHBY) could present Avastin's phase-III clinical data for treatment of renal cancer as early at the June meeting of the American ...
Genentech CEO says hasn't decided price for new Avastin uses Mar 17, 2006
MarketWatch DNA) hasn't yet decided what it will charge for its blockbuster cancer drug Avastin if it receives approval for new uses such as breast cancer and lung cancer. ...
Avastin helps breast cancer patients: study Mar 22, 2006
Reuters LONDON (Reuters) - Combining the drug Avastin with standard chemotherapy can keep breast cancer under control for longer in patients with advanced disease ...
Avastin Helps Breast Cancer Patients: Study Mar 23, 2006
Cancerpage.com, LONDON MAR 22, 2006 (Reuters) - Combining the drug Avastin with standard chemotherapy can keep breast cancer under control for longer in patients with advanced ...
Local man receives first Avastin treatment Mar 17, 2006
StarPhoenix, REGINA -- Terry Rak received his first treatment Thursday using the cancer drug Avastin -- and made his first $3,000 payment for it. ...
Saskatchewan government nixes funding for expensive cancer drug ... Mar 10, 2006
Canada.com, While Avastin may add a few months to the lives of those suffering, it is not a cure and, from a public standpoint, the costs outweigh the benefits, Health ...
Avastin, anti-Cancer Drug leads to Blindness and Other ... Mar 2, 2006
MedIndia, Researchers at the Genentech Inc.'s said that Avastin, a cancer drug may cause trigger a rare brain condition, reversible posterior leukoencephalopathy syndrome ...
Province Will Not Fund Avastin Mar 9, 2006
Saskatoonhomepage.ca, The Saskatchewan Government has decided not to cover the cost of Avastin, a new and expensive cancer drug. The drug is not a cure ...
Genentech "outperform," estimates raised Mar 31, 2006
newratings.com The company is likely to file an sBLA for Avastin, for the treatment of breast and lung cancer, in 2Q, Banc of America Securities adds. ...
Rare brain condition to be added to Avastin label Mar 3, 2006
Pharma Times (subscription), ...about a rare brain condition called reversible posterior leukoencephalopathy to the label of their blockbuster cancer drug Avastin (bevacizumab), after a ...
Avastin® Adriamycin Combination for Soft Tissue Sarcoma Mar 8, 2006
Cancer Consultants (press release), A multicenter trial has suggested that the addition of Avastin (bevacizumab) to Adriamycin (doxorubicin) improves outcomes of patients with metastatic soft ...
Dangerous divide Mar 25, 2006
Ottawa Sun, Were he still living in Ottawa, he'd be out of luck -- unless he wanted to dig very deep into his own pockets. What he needs is Avastin. ...
Genentech's Q1 Sales Of Herceptin Look Solid Mar 29, 2006
Forbes ...culled by IMS Health (nyse: RX - news - people ), a drug industry consulting firm, analyst Mark Schoenebaum said US sales of colon cancer drug Avastin in the ...
Can eye disease be staved off with a cancer drug? Mar 26, 2006
San Francisco Chronicle, The thought is awful." He'll have an hour with it while getting his left eye examined before Dr. Robert Johnson comes in with a syringe of Avastin, which would ...
Woman expects to spend $80K for US cancer drug Mar 29, 2006
Winnipeg Free Press (subscription), Winnipegger Linda Nortoft said her husband Dennis Pakulak also has advanced colon cancer and she wonders if another new drug called Avastin would be an option ...
90% of Cancer Patients Completely Unaware of New Breakthrough ... Mar 27, 2006
CNW Telbec (Communiqués de presse), The first anti-angiogenic therapy, Avastin(R) (bevacizumab), was launched a year ago for the treatment of advanced colorectal cancer, and is the only anti ...
'Starve' that tumour Mar 20, 2006
New Straits Times, A new form of treatment called Avastin has shown to be effective in helping patients with cancer of the colon or rectum live longer. RUSLINA YUSOFF writes. ...
Drug that opens a new front in the battle against breast cancer Mar 23, 2006
Times Online, A trial involving patients with advanced breast cancer given Avastin, a drug designed to block the transfer of nutrients that feed a tumour, has shown that the ...
Cancer patients step up pressure on gov't Mar 28, 2006
StarPhoenix, ...and family of colorectal cancer patients who want the NDP government to reverse its decision not to cover the cost of the pricey drug, Avastin, brought the ...
Drug that opens a new front in the battle against breast cancer Mar 23, 2006
Haber Sa?l?k, Scientists told The Times last night that the study also suggested that Avastin might be able to eradicate cancers identified before they spread beyond the ...
COMUNICADO: 90% of Cancer Patients Completely Unaware of New ... Mar 27, 2006
Europa Press, Roche and Genentech are pursuing a comprehensive clinical programme investigating the use of Avastin in advanced colorectal cancer with other chemotherapies ...
Cancer patients press government to pay for drug Mar 27, 2006
CBC Saskatchewan, Cancer patients are asking the Saskatchewan government to reconsider a decision not to cover the drug Avastin. On Monday, about ...
Britain: Breast cancer patient’s legal challenge highlights ... Mar 30, 2006
Asian Tribune, Other cancer-fighting drugs such as Avastin, Erbitux, Gleevec, Rituxan and Tarceva are also increasingly deemed too expensive and are not currently widely ...
Cancer Drug Fights Macular Degeneration Mar 27, 2006
ABC30.com, But a cancer drug called Avastin has given Rosemary much of her vision back. It appears to work better than any other wet AMD treatment. ...
No Apologies for Genentech's Prices Mar 20, 2006
BusinessWeek ...parade. The biotech has come under fire of late from patient advocates and some publications over its hit colon cancer drug, Avastin. ...
Pro-Pharmaceuticals Completes Patient Enrollment in Stage 1 of ... Mar 30, 2006
Genetic Engineering News, ...candidate, DAVANAT(R), in combination with 5-FU, leucovorin, irinotecan, doxorubicin, oxaliplatin, paclitaxel, cisplatin, and bevacizumab (AVASTIN(R)). Results ...
Half a billion in cash, but what to do with it? Mar 25, 2006
Globe and Mail, Lucentis is a fancy version of Genentech's Avastin drug, which is a leading treatment for colorectal cancer and being shown effective for breast and lung cancer ...
Colon cancer can strike even healthy people Mar 30, 2006
2TheAdvocate, Avastin, a biologic agent to target cancer cells specifically, was approved a year ago and is tripling response rates in colon cancer patients. ...
Drug to starve breast tumours Mar 23, 2006
Australian, A trial involving patients with advanced breast cancer given Avastin, a drug designed to block the transfer of nutrients that feed a tumour, has shown that the ...
New drug fights breast cancer better Mar 23, 2006
What is the Word, Medical practitioners have discovered that a new drug Avastin administered in combination with chemotherapy can considerably contain the growth of breast cancer ...
CANCER DRUG TO EXTEND LIFE Mar 25, 2006
Glasgow Sunday Mail, Now that really is something to shout about. By the time we got to the story, we found the drug Avastin won't be licensed here until next year. ...
Most cancer victims unaware of anti-angiogenesis Mar 28, 2006
News-Medical.net, The first anti-angiogenic drug Avastin was launched a year ago for the treatment of advanced colorectal cancer, and is the only anti-angiogenic agent that has ...
Most Patients Unaware of Breakthrough Drug That Could Reduce ... Mar 27, 2006
Halifax Live, The first anti-angiogenic therapy, Avastin (bevacizumab), was launched a year ago for the treatment of advanced colorectal cancer, and is the only anti ...
Genentech raises EPS forecast, approvals target Mar 17, 2006
MSNBC In the nearer term, Genentech outlined an ambitious expansion in clinical studies of the tremendously successful colon cancer drug Avastin for additional tumor ...
HL:Sask. health minister sticking to decision to not cover cost of ... Mar 28, 2006
Therapeutics Daily (subscription) (press release), The province said earlier this month that it would not pay for Avastin because it believes the drug's hefty price outweighs its benefits. ...
Paclitaxel Combined With Bevacizumab Prolongs Progression Free ... Mar 25, 2006
Medical News Today (press release), Results from a large, randomised clinical trial for patients with breast cancer show that those who received bevacizumab (Avastin®) in combination with ...
Colorectal Cancer Patients Denied Life-Extending Treatment Mar 16, 2006
CNW Telbec (Communiqués de presse), CCAC Urges Provinces to Fund Avastin MONTREAL, March 16 /CNW/ - Health Ministries in several provinces across the country have recently considered, and in some ...
Playing Catch-up Mar 28, 2006
American Enterprise Institute, The biotech cancer drugs Gleevec and Avastin, for example, are already being used to treat cancers other than the ones for which they were originally approved. ...
Targeted Agents Added to Guidelines for Non-Small Cell Lung Cancer ... Mar 20, 2006
DG News Maryland, United States. "But the most important change involved adding bevacizumab (Avastin) and erlotinib (Tarceva).". Although use ...
New breast cancer treatment 'can double life expectancy' Mar 22, 2006
Telegraph.co.uk, The patients received either the chemotherapy drug Taxol or a combination of Taxol and Avastin, which is licensed for advanced bowel cancer. ...
Genentech Says 2006 Profit Will Rise as Much as 50% (Update2) Mar 17, 2006
Bloomberg Genentech is relying on cancer drugs such as Avastin to meet its growth goals. US sales of Avastin more than doubled to $1.13 billion in 2005. ...
Genentech expects 15 treatments in four years Mar 18, 2006
San Jose Mercury News, Avastin, which the US Food and Drug Administration approved in 2004 for treating colorectal cancer, produced $1.1 billion in US sales last year. ...
Breast cancer drug cocktail hope Mar 23, 2006
BBC News, Taking Avastin, already used to treat bowel cancer, with the chemo drug Taxol led to women surviving months longer than when just taking Taxol. ...
Cancer drugs can top $100,000 a year Mar 19, 2006
Chicago Sun-Times, For example, patients with advanced colorectal cancer took Avastin ($4,400 a month) an average of 10 months in a clinical trial. ...
Cancer Center begins clinical trials Mar 20, 2006
Quincy Herald Whig, The Cancer Center's current trial is comparing two different methods of Avastin-based therapy for first-time treatment of patients with colorectal cancer that ...
Study shows Genentech drug helps slow breast cancer Mar 24, 2006
Bizjournals.com, A study of the colorectal cancer drug Avastin, made by Genentech Inc. and Roche Holding AG, showed it can slow the spread of breast ...
Drug can double breast cancer survival Mar 23, 2006
Daily Mail - UK, Scientists found Avastin kept the cancer under control for twice as long with only 'minimal' side effects. The drug blocks the growth ...
Breast cancer drug lifeline Mar 22, 2006
The Sun, In tests those who used Avastin with chemotherapy lived up to half a year more than patients using traditional treatment, a study yesterday showed. ...
NEW DRUG IN CANCER 'SUCCESS' Mar 23, 2006
Mirror.co.uk, ...reveal today. Avastin could significantly improve the chances of survival from advanced breast cancer, according to a new trial. The ...
Drug to help fight breast cancer Mar 23, 2006
United Press International The new study says a trial involving giving Avastin to those with advanced breast cancer showed the treatment significantly slowed the progression of the ...
Genentech Boosts FY06 EPS Outlook, Shares Surge - Update Mar 17, 2006
Trading Markets, ...majority owned by Swiss drugmaker Roche, had a very successful year in 2005, driven by strong sales of its cancer drugs, including the colon cancer drug Avastin ...
Warning over Herceptin hype Mar 30, 2006
Stuff.co.nz, Law said the prices of Herceptin and Avastin, another targeted cancer drug with an even higher price tag, were almost arbitrary and based on what drug ...
Health council urges NIS 466m. expansion of services Mar 29, 2006
Jerusalem Post, ...not allow the required level of medical care." He added that there remained a long list of other important drugs outside the basket, such as Avastin for colon ...
Lack of screening program criticized Mar 30, 2006
StarPhoenix, Saskatchewan Health has an obligation to cover the costs of Avastin since it hasn't instituted a colon cancer screening program, says the president of the ...
Highmark, UPMC team up to improve access to expensive cancer ... Mar 28, 2006
Pittsburgh Post Gazette, With names such as Avastin and Erbitux, the new treatments for various cancers and leukemias can require annual spending of anywhere from $10,000 to $70,000 ...
New medicines—who can afford them? Mar 3, 2006
Workers World Yet it’s true. That’s what Avastin’s manufacturer, Genentech, plans to charge for one year’s supply to treat one person with breast or lung cancer. ...
Online support is good medicine Mar 29, 2006
Contra Costa Times, ...treatment. Olson's best chance at conquering the peach may lie with Avastin, a drug recently approved for the treatment of colon cancer. ...
Excerpts from a "Peach Update": Mar 29, 2006
Contra Costa Times, One of these drugs called Avastin, but it's a current drug for colon cancer that cuts off the blood supply to the tumor so the chemo can be more affective. ...
Carol Stark: American Cancer Society has lots to offer Mar 29, 2006
Joplin Globe, ...bumps. I even learned that money donated to the ACS was used in the development of Avastin, one of the new chemo drugs I'm using. ...
Lung Cancer's Chilling Gender Bias Mar 21, 2006
Gilroy Dispatch (subscription), One new therapy is Avastin, which helps thwart the growth of blood vessels that nourish the cancer. Compared with chemotherapy alone ...
Gov't won't fund cancer drug Mar 10, 2006
StarPhoenix, ...the NDP government abandoned the principles of medicare Thursday when Health Minister Len Taylor announced the province won't cover the cost of Avastin, a drug ...
Genentech Keeps Growth Story Energized Mar 17, 2006
TheStreet.com ...rise roughly 70% thanks to consistently upbeat views from Wall Street and the various clinical achievements involving the cancer drugs Avastin and Herceptin. ...
Antibody 'puts immune system in overdrive' Mar 16, 2006
Telegraph.co.uk, ..."Other antibody drugs like Herceptin [for breast cancer], Avastin [for bowel cancer] or Humira [rheumatoid arthritis], for example, appear to be relatively ...
New skirmishes in the war on cancer Mar 22, 2006
Ars Technica, ...is the result of a clinical trial which compared the use of the standard breast cancer treatment, Taxol, to using Taxol and a blood vessel inhibitor, Avastin. ...
Drug hope for breast cancer sufferers Mar 23, 2006
Glasgow Evening Times, A study found combining the bowel cancer treatment drug Avastin with the chemotherapy drug Taxol can keep breast cancer under control for almost twice as long ...
Genentech raises its goals for progress Mar 18, 2006
TheReporter.com, Should new uses be approved in the next four years for Rituxan, Herceptin, Avastin, or Xolair - the products manufactured for commercial use at the company's ...
VHI premiums jump by two-thirds in five years Mar 23, 2006
IrishExaminer.com, ...covered. This includes drugs such as Erbitux and Avastin, used to fight colo-rectal cancer, which can cost up to €12,255 per patient. ...
Genentech "buy," target price raised Mar 20, 2006
newratings.com Genentech’s Herceptin, Avastin and Rituxan drugs are likely to be approved for additional indications going ahead, the analyst says. ...
Bitter pills Mar 17, 2006
Long Beach Press-Telegram, Genentech plans to double the price of Avastin, used to treat colon cancer, to $100,000 a year when its used is expanded to treat lung and breast cancer ...
Lpath Anticancer Drug Shows Promise in Preclinical Trials Mar 16, 2006
International News Service, ...could have on cancer treatment: "While Genentech pioneered the anti-angiogenesis approach to treating cancer with their blockbuster drug, Avastin, we believe ...
Genentech "overweight" Mar 21, 2006
newratings.com Genentech has indicated that the growth prospects of its Avastin drug are positive, which would eliminate concerns regarding the drug. ...
Roche Reviewed After Genetech Ups Guidance Mar 20, 2006
newratings.com Says with the possibility of two additional clinical trials for Avastin set to be reported this year, a likely mid-year approval of Lucentis for age-related ...
Policy on breakthrough treatments labelled unethical Mar 6, 2006
Winnipeg Free Press (subscription), Winnipeg nurse and single mother Kate Allardice can't get Avastin, which studies have shown can help patients live on average an extra five months. ...
Drugs added to cancer guidelines Mar 9, 2006
Monsters and Critics.com, ...medicine at Johns Hopkins University School of Medicine in Baltimore, Md., 'but the most important change involved adding bevacizumab (Avastin) and erlotinib ...
Thalomid® and IL-2 Effective for Metastatic Renal Cell Carcinoma Mar 20, 2006
Cancer Consultants (press release), More recently other biologic agents such as SU11248, Tarceva® and Avastin® have been reported to have significant activity in the treatment of MRCC. ...
A Cancer Drug's Big Price Rise Disturbs Doctors and Patients Mar 11, 2006
New York Times, Genentech, for example, has indicated it will effectively double the price of its colon cancer drug Avastin, to about $100,000, when Avastin's use is expanded ...
Genentech grows again in Oceanside Mar 6, 2006
North County Times, 70,000-square-foot facility will also extend Genentech's activities in Oceanside beyond its current role of making Genentech's anti-cancer medication, Avastin. ...
Huge profits display greed Mar 3, 2006
Asbury Park Press, It was recently announced that the drug Avastin, marketed by Genentech and its majority owner, Roche, was a breakthrough for the treatment of breast and lung ...
Colorectal Cancer Therapy Shows Promise Mar 14, 2006
NBC5i.com, But, in 2003, Lassiter and his new bride, Kathryn, had just heard of a new targeted therapy called Avastin that works in combination with standard chemotherapy ...
New Use For Drug Helps Patients See The Light Mar 7, 2006
13WHAM-TV, But Peterson used a new injectable drug called Avastin that appears to have stopped the progression of Lydia's disease. Avastin ...
OSI Pharma's Cancer Drug Data May Boost Stock Mar 13, 2006
Forbes The analyst expects the company to present favorable Phase II clinical trial data for combination therapy of Tarceva and Avastin next June at the annual ...
Drug coverage inconsistent Mar 14, 2006
StarPhoenix, The case of Avastin, a drug that can increase the life expectancy of colorectal cancer patients, is only the latest example in Saskatchewan. ...
ImClone’s Erbitux Receives FDA Label In Head And Neck Cancer Mar 2, 2006
BioWorld Online (subscription), Street. There’s also Avastin (bevacizumab), though that picture became clouded somewhat last month, when Genentech Inc. reported ...
Anniversary put on hold Mar 15, 2006
Times Record News, His prognosis looks good, he said, especially with the addition of the cancer drug Avastin, recently approved by the Food and Drug Administration and featured ...
Province won't cover costs of expensive cancer drug Mar 9, 2006
CBC Saskatchewan, Saskatchewan Health Minister Len Taylor says the province has decided it won't cover the cost of Avastin, an expensive new drug used to treat colorectal cancer ...
Avaricious In Germany Mar 24, 2006
Forbes ...of Taxol, for breast cancer, and a drug co-developed with Novartis that was hoped to be a pill version of Genentech's (nyse: DNA - news - people ) Avastin. ...
Drugs from llamas? Belgian firm eyes IPO next year Mar 26, 2006
Reuters ...role in a global antibody drug market that was worth $14 billion in sales last year, and includes blockbusters like Genentech's Herceptin and Avastin for cancer ...
Drugs from llamas? Belgian firm eyes IPO next year Mar 27, 2006
Reuters.uk, ...drug market that was worth $14 billion (8 billion pounds) in sales last year, and includes blockbusters like Genentech's Herceptin and Avastin for cancer. ...
EXCLUSIVE: MY CHANCE Mar 13, 2006
Mirror.co.uk, Before winning her battle - backed by the Mirror - to be prescribed "smart drug" Avastin last October, Hayley, 26, was given between two months and two years ...
More cancers in the eye of the vaccine needle Mar 28, 2006
U.S. News & World Report ...good treatment. But it's only in the last two years that we've gotten drugs like Avastin that put that principle into action. So ...
Biotech firm banks on llama DNA Mar 27, 2006
CNNMoney.com ...market that was worth $14 billion in sales last year, and includes blockbusters like Genentech's (up $0.35 to $85.28, Research) Herceptin and Avastin for cancer ...
Pharma Search Goes Underwater Mar 28, 2006
Red Herring, ...by interfering with their internal blood supply, something that could potentially complement highly profitable drugs such as Genentech’s Avastin, which works ...
Forecasts for the Approval of Several more Angiogenesis Inhibitors ... Mar 14, 2006
Business Wire (press release), The breakthrough came in 2004 when the FDA approved Genentechs bevacizumab (Avastin) for colon and rectum cancer and Eyetech Pharmaceuticals pegaptanib (Macugen ...
Onyx Pharma Set For Strong First Half 21 Dec 2005
Forbes Pfizer's Sutent and Genentech's (nyse: DNA - news - people ) Avastin will be fast on the heels of Nexavar in renal cell carcinoma (although Avastin has a ...
Debate Over the Use of Anti-VEGF Therapy in Retinal Disease 21 Dec 2005
Medscape (subscription) Which therapies will be used remains uncertain. Rosenfeld PJ. Avastin for AMD. Retina 2005: Changing concepts and controversies. ...
Biotechs may be a good bet for 2006 21 Dec 2005
CNN It has three top products: Rituxan and Herceptin, both breast cancer treatments for specific genes; and Avastin, a treatment for colorectal cancer. ...
Decision Resources Forecasts the Five Drugs that Will Achieve ... 21 Dec 2005
Drug Newswire (press release), Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and health care issues, finds that Genentech's Avastin for various ...
Reasonable premium 21 Dec 2005
Reuters ...five-year pace was 28.6%, but the growth rate picked up to 42.8% more recently, thanks to solid demand for products, including cancer products Avastin (up 78 ...
Genentech Asks For Expanded Use of Avastin and Pfizer Stocks Jump ... Dec 20, 2005
Financial News USA (press release), USA (OTC: FNWU) Genentech Inc. (NYSE: DNA) has applied for a wider use of its colon cancer drug Avastin. The South San Francisco ...
Avastin®/Femara® Combination May Be Promising for Advanced ... Dec 20, 2005
Cancer Consultants (press release), Researchers from the Memorial Sloan-Kettering Cancer Center in New York recently reported that the treatment combination of Avastin (bevacizumab) and Femara ...
New Products and Line Extensions are the Contributing Factors to ... Dec 20, 2005
Genetic Engineering News, Continued uptake of Tarceva and potential approvals for Avastin, Zactima, Erbitux and other new therapies will offset the decline in value that has come as a ...
SABCS: Low-dose Frequent Chemotherapy Plus Avastin Shows Activity ... Dec 9, 2005
MedPage Today, ...in low doses given frequently shows activity in advanced breast cancer when it is given with the angiogenesis inhibitor Avastin (bevacizumab), investigators ...
Updated Results from Phase III Trial Evaluating Addition of ... Dec 9, 2005
Cancer Consultants (press release), ...with the Eastern Cooperative Oncology Group (ECOG) recently reported updated results from the E2100 Trial in which the addition of Avastin (bevacizumab) to ...
Blockbuster Drugs Rituxan, Avastin, and Erbitux Changes the Way ... Dec 5, 2005
Genetic Engineering News, The blockbuster drugs Rituxan, Avastin, and Erbitux have changed the way the industry looks upon antibody treatment of cancer in the same way that Taxol ...
Roche "outperform" Dec 20, 2005
New Ratings According to the analysts, the consensus sales projections for Avastin for 2008 possibly include the impact of pricing reductions and no further approval of ...
Future Of Medicine In A Modern World Dec 20, 2005
News Letter, This week mother of three Hayley Newbery of Cambridge has been told that just the first dose of the drug Avastin has shrunk her tumours by an incredible 40 per ...
Cancer mum's tumour shrinks by 40% after a SINGLE dose Dec 18, 2005
Mirror.co.uk, ...for. The 26-year-old, who has colon and liver cancer, was initially denied the "smart pill" Avastin because it cost too much. But ...
Cancer drug treats macular degeneration Dec 14, 2005
Savannah Morning News, The 72-year-old widow is among an increasing number of people at risk for central vision loss who are trying Avastin, a cancer drug that inhibits the growth of ...
Xeloda®/Eloxatin®/Avastin® (XeloxA) Highly Active in Newly ... Nov 18, 2005
Cancer Consultants (press release), ...with metastatic colorectal cancer following treatment with treatment with Xeloda (capecitabine) and Eloxatin (oxapliatin) and Avastin (bevacizumab), termed the ...
Genentech heads toward completion of Oceanside plant Dec 14, 2005
North County Times, That broth contains one of the biggest-selling drugs for biotech giant Genentech Inc.: a compound called Avastin that treats metastatic cancer of the colon or ...
OXiGENE to Commence First Ever Oncology Clinical Trial Combining a ... Dec 5, 2005
PR Newswire (press release), The Company will commence a Phase Ib clinical study to evaluate CA4P in combination therapy with Avastin(R) (Bevacizumab), a drug that is owned and marketed by ...
Biotech chiefs' pay ranked Dec 20, 2005
San Jose Mercury News, Largely because of the success of its two anti-cancer drugs, Avastin and Herceptin, Genentech reported a 56 percent increase in net income for the third ...
International Approvals: Retaane, Avelox, Generic Zinnat Dec 19, 2005
Medscape (subscription) The study will enroll patients with all forms of wet AMD who are being treated with intravitreal bevacizumab (Avastin, made by Genentech, Inc). ...
Better Breast Cancer Treatment Dec 14, 2005
drkoop.com ...cancer. Instead of chemo, doctors gave her a combination of two drugs -- Herceptin (trastuzumab) and Avastin (bevacizumab). "Our ...
Under pressure, QLT restructures Dec 8, 2005
Globe and Mail, Meanwhile, Genentech's Avastin colon cancer treatment is now being used “off-label� by eye doctors to treat AMD. “The dramatic ...
QLT takes some unpleasant medicine Dec 9, 2005
Vancouver Sun (subscription), ..."Current cuts essentially balance Visudyne sales erosion which has increased due to increased Avastin use in the US market but does not alter the very ...
Frequent, Low-Dose Chemo Fights Advanced Breast Cancer Dec 8, 2005
Forbes 8 (HealthDay News) -- The combination of frequent but low doses of chemotherapy, along with the angiogenesis-inhibitor drug Avastin resulted in partial cancer ...
OXiGENE to Commence First Ever Oncology Clinical Trial Combining a ... Dec 4, 2005
Finanzen.net, Association for Cancer Research (AACR/NCI/EORTC) which showedthat the combination of CA4P with the anti-angiogenic drug, Avastin,produced significant anti ...
Low-dose chemotherapy plus antiangiogenesis drug has activity in ... Dec 8, 2005
EurekAlert (press release), In a pilot study of 55 patients, the combination of low-dose chemotherapy and the anti-VEGF antibody, bevacizumab (Avastin; Genentech) delayed the breast ...
Cancer Treatment Market for VEGF Inhibitors to Reach $5.3 Billion ... Nov 29, 2005
SeniorJournal.com, ...in this market will be fueled by increased sales of the only currently- available cancer drug in this class -- Genentech/Roche's Avastin (bevacizumab) -- as ...
Cancers use bone marrow cells to spread tumors, study finds Dec 8, 2005
Boston Globe, ...gives tumors the power to invade new tissues. Drugs such as Avastin from Genentech Inc. and Roche Holding AG that can slow blood ... |
